InvestorsHub Logo
Followers 163
Posts 3067
Boards Moderated 0
Alias Born 11/03/2014

Re: Lykiri post# 539425

Sunday, 11/27/2022 1:16:32 PM

Sunday, November 27, 2022 1:16:32 PM

Post# of 687038
Thanks Lykiri, I believe these are all different collaborations between UCLA, Merck (Keytruda / Pembrolizumab) and Bristol Meyers Squibb (BMS) (Opdivo / Nivolumab).

Also, I believe the studies are different, some combine DCVax-L + PD-1 inhibitor + CSF-1R inhibitor, and then others also add poly-ICLC

Did you have a chance to view this link?

https://reporter.nih.gov/search/cmeOHFTNlEGR3qDo7Efd5Q/project-details/9983047
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News